Coya Therapeutics, Inc. Common Stock (COYA) — Financial Flexibility Index
Coya Therapeutics, Inc. Common Stock (COYA) has a Financial Flexibility Index of -3.39x as of June 2026. Free cash flow of $-13.67 Billion (operating CF $-13.67 Billion minus capex $885.00K) represents -3% of total liabilities ($4.03 Billion). Check Coya Therapeutics, Inc. Common Stock total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Coya Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Coya Therapeutics, Inc. Common Stock across 6 annual periods. For the full cash flow conversion analysis, see COYA cash flow metrics.
Annual Financial Flexibility Index for Coya Therapeutics, Inc. Common Stock (2020–2025)
Year-by-year free cash flow to debt coverage for Coya Therapeutics, Inc. Common Stock. Explore COYA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.55x | $-10.74 Million | $-10.74 Million | $6.92 Million | ▲ +28.1% |
| 2024 | -2.16x | $-10.29 Million | $-10.29 Million | $4.77 Million | ▼ -8.5% |
| 2023 | -1.99x | $-11.19 Million | $-11.19 Million | $5.63 Million | ▼ -361.2% |
| 2022 | -0.43x | $-7.24 Million | $-7.24 Million | $16.79 Million | ▲ +86.9% |
| 2021 | -3.28x | $-3.77 Million | $-3.90 Million | $1.15 Million | ▼ -274.8% |
| 2020 | -0.88x | $-391.26K | $-391.27K | $447.12K | — |